#Datroway

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

1 week ago

Daiichi Sankyo gears up for five ADC launches in 2026

#DaiichiSankyo #ADCs #ADClaunches #Enhertu #Datroway #breastcancer #Oncology #antibodydrugconjugates #trastuzumabderuxtecan #datopotamabderuxtecan #pertuzumab #earlystagebreastcancer #triplenegativebreastcancer #Ifinatamabderuxtecan #IDXd #TROPIONBreast05study #ADCtechnology
zurl.co/TySHW

OncoDaily

@oncodaily.bsky.social

5 months ago

Paolo Tarantino: Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC - OncoDaily Paolo Tarantino: Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC / Breast Cancer, cancer, datopotamab deruxtecan, Datroway, ESMO25, OncoDaily,

Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/datop...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #TROPIONBreast02 #Datroway

OncoDaily

@oncodaily.bsky.social

5 months ago

Datopotamab-Deruxtecan Extends Survival in Metastatic TNBC Datopotamab-Deruxtecan significantly improves overall survival versus chemotherapy in first-line metastatic triple-negative breast cancer.

Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer

@astra-zeneca.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #Datroway

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

5 months ago

#breastcancer #triplenegativebreastcancer #TNBC #AstraZeneca #AZ #Datroway #datopotamabderuxtecan #DaiichiSankyo #Oncology #TNBCpatients #TROPIONBreast02trial #metastaticTNBC #immunotherapy #TNBCtumours #Gilead #TROP2ADC #Trodelvy #sacituzumabgovitecan #PFSdata
zurl.co/t8A6T

OncoDaily

@oncodaily.bsky.social

6 months ago

China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer - OncoDaily China approves Datopotamab Deruxtecan (Datroway) for advanced HR-positive, HER2-negative breast cancer after prior therapy.

China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DATROWAY #DatopotamabDeruxtecan #BreastCancer #mBC

OncoDaily

@oncodaily.bsky.social

7 months ago

Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More - OncoDaily Learn about Datopotamab Deruxtecan-dlnk (Datroway), its uses, side effects, dosage, and what to expect during treatment.

Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More

oncodaily.com/drugs/datopo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DatopotamabDeruxtecanDlnk #Datroway #LungCancer @NSCLC

pharmaphorum

@pharmaphorum.bsky.social

8 months ago

AZ, Daiichi get Datroway nod in lung cancer on second try AZ and Daiichi Sankyo have claimed FDA approval for Datroway in lung cancer after switching indications for the TROP2-directed drug.

#AstraZeneca and #DaiichiSankyo's TROP2-directed antibody-drug conjugate (#ADC) #Datroway has been granted accelerated approval from the FDA for a #lungcancer indication, seven months after withdrawing an earlier filing for the drug.